EN
HI
Zenith Drugs Chart
Zenith Drugs Share Key Metrics
Volume
1600.00
Market Cap
71.51 CR
LTQ@LTP
800@40.60
ATP
41.3
Var Margin
53.5 %
Circuit Range
33.4-50
Delivery %
0 %
Value
66080.00
ASM/GSM
No
Market Lot
800
Summary
Zenith Drugs share price is ₹40.6 as of 7 Jun, 2026. The stock Zenith Drugs intraday movement has stayed between ₹40.60 and ₹42.00, while on a 52-week basis,Zenith Drugs price 52 week high is ₹78.95 & its 52 week low is ₹33.30.
In terms of trading activity, Zenith Drugs has recorded a volume of 1600 shares, The Zenith Drugs has a market cap of ₹17148800 CR. The stock’s Average Traded Price (ATP) stands at ₹41.30, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 800 @ ₹40.60.
Zenith Drugs operates within a circuit range of ₹33.40 – ₹50.00, with a Value of ₹66080.00. The Delivery Percentage for the day is 0%. Additionally, Zenith Drugs currently falls under the No framework, and trades with a market lot size of 800.
Zenith Drugs Fundamentals
P/E Ratio
7.26
P/B Ratio
1.12
Div. Yield
0
Sector P/E
69.21
Sector P/B
2.97
Sec. Div. Yield
0.54
Zenith Drugs Resistance and Support
Pivot 41.62
Resistance
First Resistance
42.04
Second Resistance
42.37
Third Resistance
42.79
Support
First Support
41.29
Second Support
40.87
Third Support
40.54
Zenith Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results & Others |
| 2025-11-14 | Quarterly Results & Others |
| 2025-04-12 | To consider Fund Raising & Others |
Zenith Drugs News
Zenith Drugs Limited
Zenith Drugs has successfully registered its manufacturing plant and products in Afghanistan, gaining provisional approval for business operations. The company secured its first export orders worth approximately Rs. 2.50 Crores, involving 17 products. This marks a significant step in its international expansion strategy.
May 28 2026 17:34:27
Zenith Drugs Limited
Zenith Drugs board will convene on May 29, 2026, to consider and approve its audited standalone yearly financial results for the financial year ended March 31, 2026. This meeting will finalize the company's annual financial performance.
May 27 2026 13:07:11
Read More
Zenith Drugs Management
| Name | Position |
|---|---|
| Sandeep Bhardwaj | Managing Director |
| Bhupesh Soni | Executive Director |
Zenith Drugs FAQs
The Buying Price of Zenith Drugs share is 40.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zenith Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zenith Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zenith Drugs shares is 7.26. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zenith Drugs shares is 1.12. Useful to assess the stock's value relative to its book value.
To assess Zenith Drugs’s valuation compare Sector P/E, P/B which are 69.21 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zenith Drugs is 71.51 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zenith Drugs share price is 78.95 & 33.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zenith Drugs belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
Invest in ZENITHDRUG
Or Download Choice FinX App
Invest in ZENITHDRUG
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade